The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The ACR Helps Diversify Lupus Research

The ACR Helps Diversify Lupus Research

August 17, 2018 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The ACR Helps Diversify Lupus ResearchWhile African-Americans and Hispanics—especially women in these ethnic groups—are disproportionately affected by lupus, they are under-represented in clinical trials in lupus and other chronic diseases.1,2 With the help of a new federal grant, the ACR took the first step to address this lack of diversity in lupus trials this year.

You Might Also Like
  • ACR REF Niche Award Helps Define a Research Career
  • President’s Perspective: New ACR Lupus Initiative Program Helps Identify and Eliminate Bias in Rheumatology Practices
  • The ACR Supports Its Members Via Collaboration
Explore This Issue
August 2018
Also By This Author
  • Tips for Interdisciplinary Pain Management in Older Patients

The ACR’s Collaboration Initiatives (COIN) department and collaborators have launched Materials to Increase Minority Involvement in Clinical Trials (MIMICT), a new program to develop and evaluate communication strategies for clinical trial personnel. MIMICT includes free educational materials to help clinical trial investigators build relationships with each other and with referring physicians in their areas, and, ultimately, to help them effectively communicate with African-American or other minority patients with lupus. MIMICT is part of the ACR’s Lupus Initiative.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Awareness Gaps

Barriers to minority participation in lupus clinical trials may exist in part because treating physicians lack awareness about current trials and their protocols, says Sheryl McCalla, senior director, collaborative initiatives, at the ACR. Historical events may also affect some patients’ trust of the medical profession, she adds.

“The lack of diversity in clinical trials reduces opportunities for discovering potential differences in the effects treatments may have in disparate groups of patients. Diverse sampling in trials can tell us how a treatment may affect people in different patient populations,” Ms. McCalla says. “So there is a great benefit to society—to see how treatments work in different patients—and also to improve the treatment of patients in general. But there are many challenges in getting people to enroll in clinical trials.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Clinical trial results often do not reflect the actual patient population with this disease, so diversifying participation can help refine the quality of study results, says Ms. McCalla.

The ACR will expand MIMICT with the help of a new, two-year grant from the U.S. Department of Health and Human Services Office of Minority Health. This project will be led by ACR members, Saira Z. Sheikh, MD, assistant professor, rheumatology, allergy & immunology, University of North Carolina at Chapel Hill, and Allen Anandarajah, MD, MS, associate professor, allergy, immunology and rheumatology, University of Rochester Medical Center, Rochester, N.Y. If it succeeds, the model may be adapted to boost minority trial recruitment in other diseases, says Ms. McCalla. Funding for the first year is $500,000, and the second year of funding is expected to be the same, she says.

MIMICT currently focuses on primary-care providers serving African-American patients, but proposed future programs include materials for providers serving Latino patients, and nephrology and dermatology healthcare teams. In June and July, ACR staff evaluated how well MIMICT increased communication between referring providers and clinical trial sites in Georgia and North Carolina. Current materials include tips for clinical trial investigators to more effectively communicate with healthcare providers in their area and online guidebooks on ways to improve communication with African-American patients about the value of clinical trials, including the pros and cons of participation. Download MIMICT educational materials at www.thelupusinitiative.org/mimict.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Physicians Rarely Mention Trials

Atlanta attorney Christopher Reed is an African-American lupus patient serving as an advisor for the MIMICT program. Mr. Reed also serves as co-chair of advocacy for the Lupus Foundation of America’s Georgia Chapter and chair of the Advisory Council for the Georgia Council on Lupus Education Awareness. One reason African-American and Hispanic lupus patients lack awareness about currently recruiting clinical trials is that their physicians never bring up the subject, says Mr. Reed.

Pages: 1 2 3 | Single Page

Filed Under: From the College, SLE (Lupus) Tagged With: COIN, Collaboration Initiatives, Diversity, MIMICTIssue: August 2018

You Might Also Like:
  • ACR REF Niche Award Helps Define a Research Career
  • President’s Perspective: New ACR Lupus Initiative Program Helps Identify and Eliminate Bias in Rheumatology Practices
  • The ACR Supports Its Members Via Collaboration
  • COIN Delivers Lupus Education to Primary Care Physicians

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.